ArticleEJHaem2025

SGLT-2 Inhibitors Are Potent to Suppress Aggressive Transformation From Indolent Type of Adult T-Cell Leukemia/Lymphoma: Unique Insight Into Therapeutics for Diabetes-Related Hematological Malignancy.

Kazuho Morichika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.